Energy deprivation by silibinin in colorectal cancer cells: A double-edged sword targeting both apoptotic and autophagic machineries

Autophagy

Volumn 9, Issue 5, 2013, Pages 697-713

  Raina, Komal ^a   Agarwal, Chapla ^a,b   Wadhwa, Ritambhara ^a   Serkova, Natalie J ^a,b   Agarwal, Rajesh ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Autophagy; Colorectal cancer; Energy restrictions; Oxidative stress; Silibinin

Indexed keywords

CYTOCHROME C; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SILIBININ; TARGET OF RAPAMYCIN KINASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BIOLOGICAL ACTIVITY; CANCER CELL; CELL DEATH; CELL ENERGY; CELL ORGANELLE; CELL STRESS; CELL VACUOLE; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EXPOSURE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; NUTRIENT AVAILABILITY; OXIDATIVE STRESS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84877359417     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.23960     Document Type: Article

References (56)

1. American Cancer Society. Cancer Facts and Figures 2012
2. Chau I, Cunningham D. Adjuvant therapy in colon cancer-what, when and how? Ann Oncol 2006; 17:1347-59; PMID:16524974; http://dx.doi.org/10.1093/ annonc/mdl029
3. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004; 23:2891-906; PMID:15077152; http://dx.doi.org/10.1038/ sj.onc.1207521
4. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 2009; 16:761-71; PMID:19116755; http://dx.doi.org/10.1245/ s10434-008-0260-0
5. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004; 6:1221-8; PMID:15558033; http://dx.doi.org/10.1038/ncb1192
6. Thorburn A. Apoptosis and autophagy: Regulatory connections between two supposedly different processes. Apoptosis 2008; 13:1-9; PMID:17990121; http://dx.doi.org/10.1007/s10495-007-0154-9
7. Wils J, O'Dwyer P, Labianca R. Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives. Ann Oncol 2001; 12:13-22; PMID:11249040; http://dx.doi.org/10.1023/A:1008357725209
8. Kondo Y, Kondo S. Autophagy and cancer therapy. Autophagy 2006; 2:85-90; PMID:16874083
9. Reggiori F, Klionsky DJ. Autophagosomes: Biogenesis from scratch? Curr Opin Cell Biol 2005; 17:415-22; PMID:15978794; http://dx.doi.org/10.1016/j.ceb. 2005.06.007
10. Serkova NJ, Niemann CU. Pattern recognition and biomarker validation using quantitative 1H-NMRbased metabolomics. Expert Rev Mol Diagn 2006; 6:717-31; PMID:17009906; http://dx.doi.org/10.1586/14737159.6.5.717
11. Serkova NJ, Spratlin JL, Eckhardt SG. NMR-based metabolomics: Translational application and treatment of cancer. Curr Opin Mol Ther 2007; 9:572-85; PMID:18041668
12. Griffin JL, Kauppinen RA. Tumour metabolomics in animal models of human cancer. J Proteome Res 2007; 6:498-505; PMID:17269706; http://dx.doi.org/10. 1021/pr060464h
13. Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat Rev Cancer 2004; 4:551-61; PMID:15229480; http://dx.doi.org/10.1038/nrc1390
14. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, et al. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol Cancer 2008; 7:72; PMID:18799019; http://dx.doi.org/10. 1186/1476-4598-7-72
15. Wang H, Tso VK, Slupsky CM, Fedorak RN. Metabolomics and detection of colorectal cancer in humans: A systematic review. Future Oncol 2010; 6:1395-406; PMID:20919825; http://dx.doi.org/10.2217/fon.10.107
16. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003; 22:8271-82; PMID:14614451; http://dx.doi.org/10. 1038/sj.onc.1207158
17. Kaur M, Velmurugan B, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of β-catenindependent signaling. Neoplasia 2010; 12:415-24; PMID:20454513
18. Kaur M, Velmurugan B, Tyagi A, Deep G, Katiyar S, Agarwal C, et al. Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft. Mol Cancer Ther 2009; 8:2366-74; PMID:19638451; http://dx.doi.org/10.1158/1535-7163.MCT-09-0304
19. Rajamanickam S, Kaur M, Velmurugan B, Singh RP, Agarwal R. Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway. Pharm Res 2009; 26:2558-67; PMID:19779968; http://dx.doi.org/10.1007/s11095-009-9968-1
20. Rajamanickam S, Velmurugan B, Kaur M, Singh RP, Agarwal R. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res 2010; 70:2368-78; PMID:20215518; http://dx.doi.org/10.1158/0008-5472. CAN-09-3249
21. Ravichandran K, Velmurugan B, Gu M, Singh RP, Agarwal R. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice. Clin Cancer Res 2010; 16:4595-606; PMID:20823143; http://dx.doi.org/10. 1158/1078-0432.CCR-10-1213
22. Singh RP, Gu M, Agarwal R. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res 2008; 68:2043-50; PMID:18339887; http://dx.doi.org/10.1158/0008-5472.CAN-07-6247
23. Velmurugan B, Gangar SC, Kaur M, Tyagi A, Deep G, Agarwal R. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm Res 2010; 27:2085-97; PMID:20628792; http://dx.doi.org/10.1007/s11095-010-0207-6
24. Hoh C, Boocock D, Marczylo T, Singh R, Berry DP, Dennison AR, et al. Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: Silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Clin Cancer Res 2006; 12:2944-50; PMID:16675592; http://dx.doi.org/10.1158/1078-0432.CCR-05-2724
25. Hail N Jr. Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radic Biol Med 2008; 44:1382-93; PMID:18206126; http://dx.doi.org/10.1016/j.freeradbiomed.2007.12.034
26. Lin X, Li Q, Wang YJ, Ju YW, Chi ZQ, Wang MW, et al. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem J 2007; 406:215-21; PMID:17542780; http://dx.doi.org/10.1042/BJ20070186
27. Negre-Salvayre A, Augé N, Duval C, Robbesyn F, Thiers JC, Nazzal D, et al. Detection of intracellular reactive oxygen species in cultured cells using fluorescent probes. Methods Enzymol 2002; 352:62-71; PMID:12125377; http://dx.doi.org/10.1016/S0076-6879(02)52007-3
28. Zhang Z, Leonard SS, Huang C, Vallyathan V, Castranova V, Shi X. Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic Biol Med 2003; 34:1333-42; PMID:12726921; http://dx.doi.org/10.1016/S0891- 5849(03)00145-X
29. Day BJ, Batinic-Haberle I, Crapo JD. Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med 1999; 26:730-6; PMID:10218663; http://dx.doi.org/10.1016/S0891-5849(98)00261-5
30. Javvadi P, Segan AT, Tuttle SW, Koumenis C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 2008; 73:1491-501; PMID:18252805; http://dx.doi.org/10.1124/mol.107.043554
31. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, et al. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998; 1366:177-96; PMID:9714796; http://dx.doi.org/10.1016/S0005-2728(98)00112-1
32. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007; 3:542-5; PMID:17611390
33. Høyer-Hansen M, Bastholm L, Mathiasen IS, Elling F, Jäättelä M. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ 2005; 12:1297-309; PMID:15905882; http://dx.doi.org/10.1038/sj.cdd.4401651
34. Munafó DB, Colombo MI. A novel assay to study autophagy: Regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 2001; 114:3619-29; PMID:11707514
35. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4:151-75; PMID:18188003
36. Pattingre S, Bauvy C, Codogno P. Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 2003; 278:16667-74; PMID:12609989; http://dx.doi.org/10.1074/jbc.M210998200
37. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839
38. McCubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 2006; 8:1775-89; PMID:16987031; http://dx.doi.org/10.1089/ars.2006.8.1775
39. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 1998; 12:502-13; PMID:9472019; http://dx.doi.org/10.1101/gad.12.4.502
40. Jiang W, Zhu Z, Thompson HJ. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res 2008; 68:5492-9; PMID:18593953; http://dx.doi.org/10.1158/0008-5472.CAN-07-6721
41. Pyronnet S, Dostie J, Sonenberg N. Suppression of cap-dependent translation in mitosis. Genes Dev 2001; 15:2083-93; PMID:11511540; http://dx.doi.org/10.1101/gad.889201
42. Meley D, Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MT, Codogno P, et al. AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 2006; 281:34870-9; PMID:16990266; http://dx.doi.org/10. 1074/jbc.M605488200
43. Klawitter J, Anderson N, Klawitter J, Christians U, Leibfritz D, Eckhardt SG, et al. Time-dependent effects of imatinib in human leukaemia cells: A kinetic NMR-profiling study. Br J Cancer 2009; 100:923-31; PMID:19259085; http://dx.doi.org/10.1038/sj.bjc.6604946
44. Asghar U, Hawkes E, Cunningham D. Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer. Clin Colorectal Cancer 2010; 9:274-81; PMID:21208841; http://dx.doi.org/10.3816/CCC.2010.n.040
45. Desai BN, Myers BR, Schreiber SL. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A 2002; 99:4319-24; PMID:11930000; http://dx.doi.org/10.1073/pnas.261702698
46. Verfaillie T, Salazar M, Velasco G, Agostinis P. Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy. Int J Cell Biol 2010; 2010:930509; PMID:20145727; http://dx.doi.org/10.1155/2010/930509
47. Gu M, Raina K, Agarwal C, Agarwal R. Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells. Mol Carcinog 2010; 49:1-12; PMID:19544333
48. Tyagi A, Agarwal R, Agarwal C. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: Possible role in antiproliferation and apoptosis. Oncogene 2003; 22:1302-16; PMID:12618755; http://dx.doi.org/10.1038/ sj.onc.1206265
49. Bampton ET, Goemans CG, Niranjan D, Mizushima N, Tolkovsky AM. The dynamics of autophagy visualized in live cells: From autophagosome formation to fusion with endo/lysosomes. Autophagy 2005; 1:23-36; PMID:16874023; http://dx.doi.org/10.4161/auto.1.1.1495
50. Kimura S, Fujita N, Noda T, Yoshimori T. Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol 2009; 452:1-12; PMID:19200872; http://dx.doi.org/10.1016/S0076-6879(08)03601-X
51. Eskelinen EL. To be or not to be? Examples of incorrect identification of autophagic compartments in conventional transmission electron microscopy of mammalian cells. Autophagy 2008; 4:257-60; PMID:17986849
52. Mizushima N. Methods for monitoring autophagy. Int J Biochem Cell Biol 2004; 36:2491-502; PMID:15325587; http://dx.doi.org/10.1016/j.biocel. 2004.02.005
53. Ylä-Anttila P, Vihinen H, Jokitalo E, Eskelinen EL. Monitoring autophagy by electron microscopy in Mammalian cells. Methods Enzymol 2009; 452:143-64; PMID:19200881; http://dx.doi.org/10.1016/S0076-6879(08)03610-0
54. Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, Lin TA, et al. cAMP-and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci U S A 1995; 92:7222-6; PMID:7638171; http://dx.doi.org/10.1073/pnas.92.16.7222
55. Haller AA, Sarnow P. In vitro selection of a 7-methylguanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci U S A 1997; 94:8521-6; PMID:9238009; http://dx.doi.org/10.1073/pnas.94.16.8521
56. Raina K, Serkova NJ, Agarwal R. Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study. Cancer Res 2009; 69:3731-5; PMID:19366793; http://dx.doi.org/10.1158/0008-5472.CAN-09-0096